The Oncofetal Protein IMP3: A Novel Grading Tool and Predictor of Poor Clinical Outcome in Human Gliomas

Table 2

Immunohistochemical results.

Grade	IMP3 (%)	IMP3 score
III ()	6 (20%); 5 AA; 1 AO	4/6 focal (66%); 2/6 diffuse (33%)
IV ()	74 (68%)	31/74 focal (42%); 43/74 diffuse (58%)